Found 91 matching trials
GSK159802 In Healthy Male Subjects And Asthmatics PHASE1 GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease PHASE4 The purpose of this study is to evaluate a new questionnaire to capture the...
Show More Location
GSK Investigational Site
Learn More & Join Trial
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients PHASE3 The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Show More Location
Combined Research Orlando
Learn More & Join Trial
A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50 PHASE3 To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects PHASE2 This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease PHASE2 The purpose of the study is to determine the appropriate dose of fluticason...
Show More Learn More & Join Trial
Symbicort Onset of Action 1 PHASE3 The purpose of this study is to compare the early onset of effect of Symbic...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 This randomized, cross over study aims to find out the benefits of deliveri...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The primary objective of this trial was to establish non-inferiority of lun...
Show More Location
Multiple Locations
Learn More & Join Trial